« Morning Smoke: Taxpayers Getting Burned By Duplicative Government Programs | Main | Supreme Court Rejects Corporate "Personal Privacy" FOIA Argument »

Mar 01, 2011

TrackBack

TrackBack URL for this entry:
http://www.typepad.com/services/trackback/6a00d8341c68bf53ef0147e2eb7b4d970b

Listed below are links to weblogs that reference The National Institutes of Health NOT Friendly to Ghostwriting:

Comments

Paul Thacker

Dr. Nardo,

Thanks for the comment. I'm writing a follow-up with more analysis, that we will post soon.

Keep following!

John M. Nardo MD

I appreciate Collins' response, but as you are quoted on Pharmalot, it doesn't go far enough. It's not the pay to authors that matters, it's their other benefits. In reviewing the whole lot of AstraZeneca/Seroquel published Clinical Trials, I'm convinced that they were written by contract writers at Parexel [acknowledged as writing support]. of particular interest is an interchange with Dr. Nassir Ghaemi in 2004, summarized here. This ghost is bigger than just a writer, a better term would be ghost-research. Keep up your very important work!

The comments to this entry are closed.